Paul Campbell

Comptroller/Controller/Auditor at VIATRIS INC.

Net worth: 2 M $ as of 2024-03-30

57 year

Health Technology

Profile

Paul B.
Campbell is currently the Chief Accounting Officer & Controller at Viatris, Inc. He previously worked at Mylan NV as the Chief Accounting Officer, Interim CFO & Senior VP.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
VIATRIS, INC. 0.01%	2024-03-04	154,144 ( 0.01% )	2 M $	2024-03-30

Paul Campbell active positions

Companies	Position	Start
VIATRIS INC.	Comptroller/Controller/Auditor	2020-11-15

All active positions of Paul Campbell

Former positions of Paul Campbell

Companies	Position	End
Mylan NV Mylan NV Pharmaceuticals: MajorHealth Technology Mylan NV is a pharmaceutical healthcare company. The firm engages in the development, license, manufacture, market and distribution of generic, branded generic and specialty pharmaceutical products. It operates through the following geographical segments: North America, Europe and Rest of World. The North America segment develops, manufactures, sells, and distributes pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized and cream, or ointment form. The Europe segment operates through subsidiaries in Italy, Germany, the United Kingdom, and Spain. The Rest of World segment comprises of operations in Japan, Australia, China, Brazil, Russia, India, South Africa, Middle East and South East Asia. The company was founded in 1961 and is headquartered in Hatfield, the United Kingdom.	Director of Finance/CFO	-

See the detail of Paul Campbell's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Paul Campbell's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
VIATRIS INC.	Health Technology

Private companies	1
Mylan NV Mylan NV Pharmaceuticals: MajorHealth Technology Mylan NV is a pharmaceutical healthcare company. The firm engages in the development, license, manufacture, market and distribution of generic, branded generic and specialty pharmaceutical products. It operates through the following geographical segments: North America, Europe and Rest of World. The North America segment develops, manufactures, sells, and distributes pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized and cream, or ointment form. The Europe segment operates through subsidiaries in Italy, Germany, the United Kingdom, and Spain. The Rest of World segment comprises of operations in Japan, Australia, China, Brazil, Russia, India, South Africa, Middle East and South East Asia. The company was founded in 1961 and is headquartered in Hatfield, the United Kingdom.	Health Technology